We are live on
!
Find out more
AWM
Avitas Wealth Management Portfolio holdings
AUM
$723M
1-Year Est. Return
33.35%
This Fund
S&P 500
This Quarter
Est. Return
+4.47%
1 Year Est. Return
+33.35%
3 Year Est. Return
+56.18%
5 Year Est. Return
+244.92%
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$11.5M
(+1.6%)
Cap. Flow
-$4.36M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
36.1%
Holding
204
New
7
Increased
72
Reduced
111
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$7.58M |
| 2 |
Applied Materials
AMAT
|
+$1.81M |
| 3 |
Cardinal Health
CAH
|
+$1.45M |
| 4 |
Eli Lilly
LLY
|
+$1.34M |
| 5 |
Zoetis
ZTS
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$2.7M |
| 2 |
Pfizer
PFE
|
+$2.48M |
| 3 |
Elevance Health
ELV
|
+$2.43M |
| 4 |
Microchip Technology
MCHP
|
+$1.93M |
| 5 |
Rio Tinto
RIO
|
+$1.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.94% |
| 2 | Financials | 12.92% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Healthcare | 8.27% |
| 5 | Communication Services | 7.76% |
No holdings matched the selected filter criteria.
Similar funds
TW
NRA
PW
BCMO
HB
PPP
SWM
DWM
Avitas Wealth Management's Q4 2024 Portfolio in Review
As of Q4 2024, Avitas Wealth Management held 204 positions worth $723M, up 1.6% from $711M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Avitas Wealth Management's Q4 2024 filing shows 7 new, 72 increased, 111 reduced and 14 closed positions. Its largest new stake was Cardinal Health: 12,395 shares worth $1.47M. The largest sale was Amgen, an estimated $2.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Avitas Wealth Management's largest Q4 2024 buy was Cardinal Health: 12,395 shares worth $1.47M.
- Avitas Wealth Management added most to State Street Health Care Select Sector SPDR ETF in Q4 2024, an estimated $7.58M increase.
- Avitas Wealth Management's biggest Q4 2024 reduction was AstraZeneca, cutting an estimated $1.33M.
- Avitas Wealth Management fully exited Amgen in Q4 2024, selling an estimated $2.7M.
- Avitas Wealth Management's ten largest holdings make up 36% of its $723M portfolio in Q4 2024.
- Avitas Wealth Management opened 7 new positions and closed 14 in Q4 2024.
- Avitas Wealth Management's portfolio value rose 1.6% quarter-over-quarter to $723M.
Based on Avitas Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.